Accelerator Life Science Partners Launches Magnolia NeurosciencesCorporation with $31 Million Series A to Develop TargetedNeuroprotective Therapies

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2Ozdz78
via IFTTT